ArticleGynecologic oncology2012

RhoB mediates antitumor synergy of combined ixabepilone and sunitinib in human ovarian serous cancer.

Prakash Vishnu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.